I'm surprised that the market didn't take today's HY21 results as incredibly positive.
Anyone more educated than me have an idea?
With the storm of COVID largely weathered, significant improvements in net operating margin, mention of a dividend on the horizon, and a "low risk" industry in medical supplies, I feel like this is significantly undervalued.
Am I missing something in the report that others are seeing? Genuinely curious, I'm hoping someone more experienced than me can share some insight!
Ann: HY21 Results Presentation, page-2
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PGC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
42.0¢ |
Change
0.005(1.20%) |
Mkt cap ! $695.2M | |||
| Open | High | Low | Value | Volume |
| 41.5¢ | 42.0¢ | 41.0¢ | $513.7K | 1.232M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 125685 | 41.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.0¢ | 230201 | 7 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| PGC (ASX) Chart |